Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Reinvestment Rate
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $32.00K (capex $32.00K ) from operating cash flow of $44.89 Million. Explore how much does Catalyst Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Catalyst Pharmaceuticals Inc across 7 annual periods. Also explore CPRX total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Catalyst Pharmaceuticals Inc. For live market cap and broader valuation context, see CPRX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $58.00K | $208.67 Million | $58.00K | ▼ -94.0% |
| 2024 | 0.00x | $1.11 Million | $239.81 Million | $556.00K | ▼ -99.8% |
| 2023 | 2.35x | $336.93 Million | $143.60 Million | $81.74 Million | ▲ +1313.2% |
| 2022 | 0.17x | $19.27 Million | $116.05 Million | $29.00K | ▼ -9.1% |
| 2021 | 0.18x | $11.02 Million | $60.37 Million | $1.02 Million | ▲ +63.7% |
| 2020 | 0.11x | $5.02 Million | $45.03 Million | $11.39K | ▼ -89.6% |
| 2019 | 1.08x | $37.26 Million | $34.61 Million | $19.37K | — |